Montagna Georgina N, Beigier-Bompadre Macarena, Becker Martina, Kroczek Richard A, Kaufmann Stefan H E, Matuschewski Kai
Parasitology Unit, Max Planck Institute for Infection Biology, Berlin, Germany
Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany.
mBio. 2014 Jul 29;5(4):e01321-14. doi: 10.1128/mBio.01321-14.
Protective immunity against preerythrocytic malaria parasite infection is difficult to achieve. Intracellular Plasmodium parasites likely minimize antigen presentation by surface-expressed major histocompatibility complex class I (MHC-I) molecules on infected cells, yet they actively remodel their host cells by export of parasite factors. Whether exported liver-stage proteins constitute better candidates for MHC-I antigen presentation to CD8(+) T lymphocytes remains unknown. Here, we systematically characterized the contribution of protein export to the magnitude of antigen-specific T-cell responses against Plasmodium berghei liver-stage parasites in C57BL/6 mice. We generated transgenic sporozoites that secrete a truncated ovalbumin (OVA) surrogate antigen only in the presence of an amino-terminal protein export element. Immunization with live attenuated transgenic sporozoites revealed that antigen export was not critical for CD8(+) T-cell priming but enhanced CD8(+) T-cell proliferation in the liver. Upon transfer of antigen-specific CD8(+) T cells, liver-stage parasites secreting the target protein were eliminated more efficiently. We conclude that Plasmodium parasites strictly control protein export during liver infection to minimize immune recognition. Strategies that enhance the discharge of parasite proteins into infected hepatocytes could improve the efficacy of candidate preerythrocytic malaria vaccines. Importance: Vaccine development against Plasmodium parasites remains a priority in malaria research. The most advanced malaria subunit vaccine candidates contain Plasmodium surface proteins with important roles for parasite vital functions. A fundamental question is whether recognition by effector CD8(+) T cells is restricted to sporozoite surface antigens or extends to parasite proteins that are synthesized during the extensive parasite expansion phase in the liver. Using a surrogate model antigen, we found that a cytoplasmic antigen is able to induce robust protective CD8(+) T-cell responses, but protein export further enhances immunogenicity and protection. Our results show that a cytoplasmic localization does not exclude a protein's candidacy for malaria subunit vaccines and that protein secretion can enhance protective immunity.
实现针对疟原虫感染前红细胞期寄生虫的保护性免疫十分困难。细胞内疟原虫寄生虫可能会尽量减少受感染细胞表面表达的主要组织相容性复合体I类(MHC-I)分子的抗原呈递,但它们会通过输出寄生虫因子来积极重塑宿主细胞。输出的肝期蛋白是否构成更好的MHC-I抗原呈递给CD8(+) T淋巴细胞的候选物仍不清楚。在这里,我们系统地研究了蛋白质输出对C57BL/6小鼠中针对伯氏疟原虫肝期寄生虫的抗原特异性T细胞反应强度的贡献。我们构建了仅在氨基末端蛋白质输出元件存在时才分泌截短卵清蛋白(OVA)替代抗原的转基因子孢子。用减毒活转基因子孢子免疫显示,抗原输出对CD8(+) T细胞启动并不关键,但可增强肝脏中CD8(+) T细胞的增殖。转移抗原特异性CD8(+) T细胞后,分泌靶蛋白的肝期寄生虫被更有效地清除。我们得出结论,疟原虫在肝脏感染期间严格控制蛋白质输出,以尽量减少免疫识别。增强寄生虫蛋白向受感染肝细胞释放的策略可能会提高候选疟疾感染前疫苗的效力。重要性:针对疟原虫的疫苗开发仍然是疟疾研究的重点。最先进的疟疾亚单位疫苗候选物包含对寄生虫重要生命功能起重要作用的疟原虫表面蛋白。一个基本问题是效应CD8(+) T细胞的识别是否仅限于子孢子表面抗原,还是扩展到在肝脏中广泛的寄生虫扩增阶段合成的寄生虫蛋白。使用替代模型抗原,我们发现一种细胞质抗原能够诱导强大的保护性CD8(+) T细胞反应,但蛋白质输出进一步增强了免疫原性和保护性。我们的结果表明,细胞质定位并不排除蛋白质作为疟疾亚单位疫苗的候选资格,并且蛋白质分泌可以增强保护性免疫。